Concepts (137)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Progestins | 4 | 2023 | 306 | 2.430 |
Why?
|
Asthma | 11 | 2023 | 6011 | 1.480 |
Why?
|
Drug Hypersensitivity | 5 | 2022 | 883 | 1.310 |
Why?
|
Hypersensitivity | 3 | 2022 | 1102 | 1.180 |
Why?
|
Gender Identity | 5 | 2024 | 688 | 1.060 |
Why?
|
Anaphylaxis | 2 | 2023 | 746 | 0.950 |
Why?
|
Desensitization, Immunologic | 5 | 2023 | 483 | 0.880 |
Why?
|
Diabetes Mellitus, Type 2 | 5 | 2023 | 11732 | 0.790 |
Why?
|
Asthma, Aspirin-Induced | 1 | 2023 | 182 | 0.740 |
Why?
|
Hypersensitivity, Immediate | 1 | 2022 | 337 | 0.700 |
Why?
|
Dipeptidyl-Peptidase IV Inhibitors | 1 | 2023 | 293 | 0.690 |
Why?
|
Progesterone | 2 | 2023 | 776 | 0.640 |
Why?
|
beta-Lactams | 1 | 2019 | 160 | 0.600 |
Why?
|
Dermatitis | 1 | 2018 | 197 | 0.570 |
Why?
|
Transsexualism | 1 | 2019 | 178 | 0.550 |
Why?
|
Homebound Persons | 2 | 2011 | 49 | 0.490 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 3 | 2023 | 3047 | 0.480 |
Why?
|
Electronic Health Records | 9 | 2024 | 4463 | 0.440 |
Why?
|
Allergens | 1 | 2019 | 1320 | 0.400 |
Why?
|
Cystic Fibrosis | 1 | 2019 | 1178 | 0.360 |
Why?
|
Hypoglycemic Agents | 4 | 2023 | 2875 | 0.340 |
Why?
|
Lipid Metabolism | 1 | 2017 | 1888 | 0.320 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2019 | 1356 | 0.310 |
Why?
|
Autoimmune Diseases | 1 | 2018 | 2136 | 0.280 |
Why?
|
Receptors, Thromboxane | 1 | 2023 | 31 | 0.240 |
Why?
|
Urban Population | 1 | 2011 | 2021 | 0.230 |
Why?
|
Bronchial Spasm | 1 | 2022 | 73 | 0.220 |
Why?
|
Blood Glucose | 1 | 2017 | 6259 | 0.210 |
Why?
|
Sulfonylurea Compounds | 1 | 2023 | 204 | 0.210 |
Why?
|
Humans | 36 | 2024 | 744220 | 0.210 |
Why?
|
Receptors, Neuropeptide | 1 | 2022 | 111 | 0.210 |
Why?
|
Cell Degranulation | 1 | 2022 | 287 | 0.200 |
Why?
|
Obesity | 1 | 2023 | 12742 | 0.200 |
Why?
|
Electronic Mail | 1 | 2023 | 213 | 0.200 |
Why?
|
Menstrual Cycle | 1 | 2023 | 551 | 0.180 |
Why?
|
Platelet Activation | 1 | 2023 | 673 | 0.180 |
Why?
|
Cetirizine | 1 | 2019 | 7 | 0.170 |
Why?
|
Famotidine | 1 | 2019 | 16 | 0.170 |
Why?
|
Length of Stay | 2 | 2011 | 6308 | 0.170 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2021 | 340 | 0.170 |
Why?
|
Demography | 1 | 2024 | 1656 | 0.170 |
Why?
|
Mastocytosis | 1 | 2021 | 160 | 0.160 |
Why?
|
Skin Tests | 1 | 2020 | 612 | 0.160 |
Why?
|
Sulfides | 1 | 2019 | 166 | 0.160 |
Why?
|
GTP-Binding Proteins | 1 | 2022 | 970 | 0.160 |
Why?
|
Anti-Asthmatic Agents | 1 | 2023 | 536 | 0.160 |
Why?
|
Mast Cells | 2 | 2022 | 1544 | 0.160 |
Why?
|
Spirometry | 1 | 2021 | 864 | 0.160 |
Why?
|
Acetates | 1 | 2019 | 313 | 0.150 |
Why?
|
Cyclopropanes | 1 | 2019 | 416 | 0.150 |
Why?
|
Biological Specimen Banks | 1 | 2022 | 712 | 0.150 |
Why?
|
Retrospective Studies | 7 | 2024 | 77426 | 0.150 |
Why?
|
Tissue Culture Techniques | 1 | 2017 | 290 | 0.130 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2022 | 1221 | 0.130 |
Why?
|
Health Services Accessibility | 1 | 2011 | 5138 | 0.120 |
Why?
|
Female | 14 | 2024 | 380197 | 0.120 |
Why?
|
Quinolines | 1 | 2019 | 730 | 0.120 |
Why?
|
Glucose Tolerance Test | 1 | 2017 | 1150 | 0.120 |
Why?
|
Contraception | 1 | 2017 | 359 | 0.120 |
Why?
|
Antibiotic Prophylaxis | 1 | 2019 | 638 | 0.120 |
Why?
|
Weight Loss | 1 | 2023 | 2622 | 0.110 |
Why?
|
Pharmaceutical Preparations | 1 | 2020 | 1071 | 0.100 |
Why?
|
Life Style | 1 | 2023 | 3835 | 0.100 |
Why?
|
Comorbidity | 2 | 2023 | 10387 | 0.100 |
Why?
|
Aspirin | 1 | 2023 | 3282 | 0.100 |
Why?
|
Anti-Infective Agents | 1 | 2019 | 972 | 0.100 |
Why?
|
Bone Density | 2 | 2014 | 3468 | 0.100 |
Why?
|
Amino Acid Sequence | 1 | 2023 | 13817 | 0.090 |
Why?
|
Prospective Studies | 3 | 2023 | 53280 | 0.090 |
Why?
|
Islets of Langerhans | 1 | 2017 | 1350 | 0.090 |
Why?
|
Respiratory Insufficiency | 1 | 2019 | 1199 | 0.090 |
Why?
|
Immune Tolerance | 1 | 2019 | 2258 | 0.090 |
Why?
|
Nerve Tissue Proteins | 1 | 2022 | 4465 | 0.090 |
Why?
|
Fertilization in Vitro | 1 | 2017 | 1284 | 0.090 |
Why?
|
Serotonin | 1 | 2014 | 1023 | 0.090 |
Why?
|
Artificial Intelligence | 1 | 2021 | 2213 | 0.080 |
Why?
|
Nurse Practitioners | 1 | 2011 | 270 | 0.080 |
Why?
|
Cholesterol, LDL | 1 | 2017 | 2355 | 0.080 |
Why?
|
Waiting Lists | 1 | 2011 | 693 | 0.080 |
Why?
|
Male | 10 | 2024 | 350027 | 0.070 |
Why?
|
Homeostasis | 1 | 2017 | 3339 | 0.070 |
Why?
|
Evidence-Based Medicine | 1 | 2017 | 3611 | 0.060 |
Why?
|
Adult | 6 | 2023 | 214035 | 0.060 |
Why?
|
Middle Aged | 7 | 2021 | 213367 | 0.060 |
Why?
|
Aged, 80 and over | 4 | 2021 | 57768 | 0.060 |
Why?
|
Disease Progression | 1 | 2021 | 13280 | 0.060 |
Why?
|
Risk Factors | 3 | 2021 | 72280 | 0.060 |
Why?
|
Inflammation | 1 | 2023 | 10634 | 0.060 |
Why?
|
Infant, Newborn | 1 | 2024 | 25618 | 0.060 |
Why?
|
Continuity of Patient Care | 1 | 2011 | 1049 | 0.060 |
Why?
|
Aged | 6 | 2021 | 163253 | 0.060 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3132 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3239 | 0.050 |
Why?
|
Case-Control Studies | 2 | 2017 | 21752 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2020 | 5755 | 0.050 |
Why?
|
Hospitalization | 3 | 2022 | 10262 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2017 | 7281 | 0.050 |
Why?
|
Pandemics | 1 | 2020 | 8387 | 0.050 |
Why?
|
Mutation | 2 | 2014 | 29784 | 0.040 |
Why?
|
Cough | 1 | 2022 | 555 | 0.040 |
Why?
|
Respiratory Sounds | 1 | 2022 | 696 | 0.040 |
Why?
|
Pilot Projects | 1 | 2011 | 8321 | 0.040 |
Why?
|
Cohort Studies | 1 | 2021 | 40559 | 0.040 |
Why?
|
Prognosis | 1 | 2018 | 29050 | 0.040 |
Why?
|
Comparative Effectiveness Research | 1 | 2023 | 681 | 0.040 |
Why?
|
Immunoglobulin E | 1 | 2023 | 1463 | 0.040 |
Why?
|
Patients | 1 | 2023 | 900 | 0.040 |
Why?
|
Mice | 1 | 2023 | 81178 | 0.040 |
Why?
|
Documentation | 1 | 2022 | 869 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 15161 | 0.030 |
Why?
|
Osteoprotegerin | 1 | 2014 | 176 | 0.030 |
Why?
|
Natural Language Processing | 1 | 2021 | 1040 | 0.030 |
Why?
|
United States | 1 | 2021 | 69867 | 0.030 |
Why?
|
RANK Ligand | 1 | 2014 | 326 | 0.030 |
Why?
|
Adolescent | 2 | 2020 | 85759 | 0.030 |
Why?
|
Animals | 1 | 2023 | 168788 | 0.020 |
Why?
|
Young Adult | 1 | 2016 | 56436 | 0.020 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2014 | 838 | 0.020 |
Why?
|
Genetic Markers | 1 | 2014 | 2634 | 0.020 |
Why?
|
Massachusetts | 1 | 2020 | 8663 | 0.020 |
Why?
|
Survival Analysis | 1 | 2020 | 10250 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2020 | 3680 | 0.020 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2014 | 1676 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 3871 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10396 | 0.020 |
Why?
|
Primary Health Care | 1 | 2021 | 4556 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2011 | 2886 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2014 | 2586 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2014 | 2915 | 0.010 |
Why?
|
Prevalence | 1 | 2020 | 15226 | 0.010 |
Why?
|
Age Factors | 1 | 2020 | 18367 | 0.010 |
Why?
|
Algorithms | 1 | 2023 | 13885 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15538 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2014 | 4553 | 0.010 |
Why?
|
Genotype | 1 | 2014 | 12956 | 0.010 |
Why?
|
Patient Discharge | 1 | 2011 | 3313 | 0.010 |
Why?
|
Patient Readmission | 1 | 2011 | 3114 | 0.010 |
Why?
|
Concepts
(137)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(52)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_